Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.1.21 (
thymidine kinase
)
7,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The discovery of germ cell-specific general transcription factor and coactivator variants has suggested that reproductive tissues control gene expression somewhat differently than somatic tissues. One of these factors, ALF (TFIIAtau), was first described as a testis-specific counterpart of the large (alpha/beta) subunit of
TFIIA
. Here we characterize endogenous ALF and
TFIIA
activities in the African clawed frog Xenopus laevis. ALF is present in both testis and ovary in this organism, and it completely replaces
TFIIA
in immature oocytes. When oocytes undergo progesterone-induced maturation, ALF activity disappears, and
TFIIA
activity is restored. Reactivation occurs through the translational up-regulation of two maternal TFIIAalpha/beta mRNAs and involves polyadenylation of a conserved 3'-untranslated region module. The effects of ALF overexpression and ALF immunodepletion on a
thymidine kinase
promoter construct demonstrate that this factor serves as an active replacement for
TFIIA
. In contrast, overexpression of
TFIIA
inhibits transcription, indicating that the somatic factor fails to function properly in the context of the oocyte transcription machinery. Overall, the results show that the translationally regulated reciprocal expression of ALF and
TFIIA
allows for the production of an active
TFIIA
-like general transcription factor throughout oogenesis.
...
PMID:Expression of the germ cell-specific transcription factor ALF in Xenopus oocytes compensates for translational inactivation of the somatic factor TFIIA. 1292 89